Inhibition of Stat3 by cell-permeable peptidomimetic prodrugs targeted to its SH2 domain.
McMurray
John S
JS
Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Mandal
Pijus K
PK
Liao
Warren S
WS
Ren
Zhiyong
Z
Chen
Xiaomin
X
D045744:Cell Line, Tumor; D006801:Humans; D018716:Molecular Mimicry; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology*; D010766:Phosphorylation; D011355:Prodrugs / Q000494:pharmacology*; D050796:STAT3 Transcription Factor / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship; D018909:src Homology Domains
D010455:Peptides; D011355:Prodrugs; D050796:STAT3 Transcription Factor